Live Breaking News & Updates on Himalaya Therapeutics

Stay updated with breaking news from Himalaya therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Himalaya Therapeutics Announces Highlights of Recent Clinical Progress

/PRNewswire/ Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of. ....

Nicholas Desjardins , Brian Zhang , Mecbotamab Vedotin , Ozuriftamab Vedotin , Bioatla Inc , Pleomorphic Sarcoma , Dose Limiting Toxicities , Serious Adverse Events , Himalaya Therapeutics , Conditionally Active Biologics , Greater China , Operational Updates , Soft Tissue , Primary Bone , Escalation Trial , Across Multiple Solid Tumor Types , Himalaya Therapeutics Sezc ,

Himalaya Therapeutics Announces Interim Phase 2 Results for Mecbotamab vedotin (HTBA3011)

/PRNewswire/ Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization of a novel class of. ....

Howe Li , Nicholas Desjardins , Brian Zhang , Non Small Cell Lung Cancer , Pleomorphic Sarcoma , Himalaya Therapeutics , Conditionally Active Biologics , Greater China , Himalaya Therapeutics Sezc ,

Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC

/PRNewswire/ Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization in Greater China,. ....

Hong Kong , Howe Li , Nicholas Desjardins , Brian Zhang , China National Medical Products Association , Himalaya Therapeutics , Greater China , Conditionally Active Biologics , Drug Evaluation , Mainland China , Himalaya Therapeutics Sezc , Health Care Amp Hospitals , Biotechnology , Medical Pharmaceuticals , International Medical Approval ,

Himalaya Therapeutics Announces Submission in Mainland China of IND Applications for its CAB-AXL-ADC to treat sarcomas and NSCLC, its CAB-ROR2-ADC to treat melanoma and NSCLC

/PRNewswire/ Himalaya Therapeutics ("Himalaya"), a clinical-stage biopharmaceutical company focused on development and commercialization in Greater China,. ....

Hong Kong , Howe Li , Nicholas Desjardins , Brian Zhang , China National Medical Products Association , Himalaya Therapeutics , Greater China , Conditionally Active Biologics , Drug Evaluation , Mainland China , Himalaya Therapeutics Sezc ,

Himalaya Therapeutics Announces Registration of its Office in Shanghai

Himalaya Therapeutics Announces Registration of its Office in Shanghai
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Hong Kong , Howe Li , Nicholas Desjardins , Brian Zhang , Himalaya Therapeutics , Greater China , Conditionally Active Biologics ,